PCPaula S. Chaves

Paula S. Chaves

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paula S. Chaves has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Ruy Carlos Ruver Beck

    Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia Universidade Federal do Rio Grande do Sul, Avenida Ipiranga, 2752, Porto Alegre, Rio Grande do Sul 90610-000, Brazil

    2 shared publications
  • Adriana Raffin Pohlmann

    Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Núcleo de Terapias Nanotecnológicas (NTnano), Faculdade de Farmácia da Universidade Federal do Rio Grande do Sul, Brazil

    1 shared publication
  • Andressa Bernardi

    Laboratory of Inflammation, Oswaldo Cruz Institute (IOC) Oswaldo Cruz Foundation (Fiocruz) Rio de Janeiro Brazil

    1 shared publication
  • Andréia Buffon

    Laboratório de Análises Bioquímicas e Citológicas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil

    1 shared publication
  • Camila Mariot

    Hematology and Flow Cytometry Unit, Laboratory Diagnosis Service, Hospital de Clinicas de Porto Alegre

    1 shared publication
  • Diogo André Pilger

    Laboratório de Análises Bioquímicas e Citológicas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

    1 shared publication

Latest Publications

  • Open Access

    Fatty acid synthase as a potential new therapeutic target for cervical cancer

    by Jéssica Nascimento, Camila Mariot, Débora R.B. Vianna, Lúcia M. Kliemann, Paula S. Chaves, Massimo Loda, Andréia Buffon, Ruy C.R. Beck, Diogo A. Pilger

    Fatty acid synthase (FASN) is the rate-limiting enzyme for the de novo synthesis of fatty acids in the cytoplasm of tumour cells. Many tumour cells express high levels of FASN, and its expression is associated with a poorer prognosis. Cervical cancer is a major public health problem, representing the fourth most common cancer affecting women worldwide. To date, only a few in silico studies have correlated FASN expression with cervical cancer. This study aimed to investigate in vitro FASN expression in premalignant lesions and cervical cancer samples and the effects of a FASN inhibitor on cervical cancer cells. FASN expression was observed in all cervical cancer samples with increased expression at more advanced cervical cancer stages. The FASN inhibitor (orlistat) reduced the in vitro cell viability of cervical cancer cells (C-33A, ME-180, HeLa and SiHa) in a time-dependent manner and triggered apoptosis. FASN inhibitor also led to cell cycle arrest and autophagy. FASN may be a potential therapeutic target for cervical cancer, and medicinal chemists, pharmaceutical researchers and formulators should consider this finding in the development of new treatment approaches for this cancer type.


  • Castor oil and mineral oil nanoemulsion: development and compatibility with a soft contact lens

    by Tatiele Katzer, Paula Chaves, Andressa Bernardi, Adriana R. Pohlmann, Silvia S. Guterres, Ruy C. R. Beck

    Context: The non-invasive ophthalmic therapy has a drawback: low residence time in the eye socket. Nanoparticles and contact lenses have been studied as promising ocular drug delivery systems. Objective: To develop a nanoemulsion and evaluate its compatibility with a soft contact lens as a potential strategy for ocular delivery. Materials and methods: The formulations were developed by spontaneous emulsification and fully characterized. Two drops of nanoemulsion were instilled on the surface of a commercial contact lens and its transparency was measured using a UV-Vis spectrophotometer. Before and after the instillation of the drops, the morphology (scanning electron microscopy – SEM) and ion permeability of the lenses were analyzed. Results: The formulations had a mean particle size of 234 nm, polydispersity below 0.16, zeta potential of −8.56 ± 3.49 mV, slightly acid pH, viscosity ≈1.2 mPa s−1 and spherical-shaped particles. Nanoemulsion was non-irritant (hen’s egg test-chorioallantoic membrane), which was confirmed by the cytotoxicity studies in the SIRC cell cultures. After instillation, SEM analysis showed nanodroplets inside and on the surface of the lenses, although their transparency remained near 100%. No significant differences were found between lens ion permeability coefficients before and after instillation. Conclusions: Formulations presented appropriate physicochemical characteristics and suitability for ocular application. The contact lens remained transparent and ion-permeable after association with the formulation.